Page 6 - Harald Rau News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harald rau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harald Rau Today - Breaking & Trending Today

Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to Hold at StockNews.com

Ascendis Pharma A/S (NASDAQ:ASND – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. Other equities research analysts also recently issued research reports about the company. Bank of America dropped their target price on Ascendis Pharma A/S from $132.00 […] ....

United States , Jan Moller Mikkelsen , Harald Rau , Ascendis Pharma , Dirk Vetter , Credit Suisse Group , Envestnet Asset Management Inc , Ascendis Pharmaas Company Profile , York Mellon Corp , Blackrock Inc , Affinity Asset Advisors , Morgan Stanley , Rice Hall James Associates , Get Rating , Suisse Group , Asset Management , Hall James , New York Mellon Corp , Ascendis Pharmaa S , Nasdaq Asnd , Stocknews Com ,

Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Reaffirmed by 3M

Ascendis Pharma A/S (NASDAQ:ASND – Get Rating)‘s stock had its “maintains” rating reissued by equities research analysts at 3M in a report released on Friday, Benzinga reports. A number of other research analysts also recently issued reports on the stock. Oppenheimer downgraded shares of Ascendis Pharma A/S from an “outperform” rating to a “market perform” […] ....

Dirk Vetter , Ascendis Pharma , Harald Rau , Jan Moller Mikkelsen , Morgan Stanley , Blackrock Inc , Rice Hall James Associates , Cantor Fitzgerald , Affinity Asset Advisors , Ascendis Pharmaas Company Profile , York Mellon Corp , Envestnet Asset Management Inc , Get Rating , Asset Management , Hall James , New York Mellon Corp , Ascendis Pharmaa S , Nasdaq Asnd , Reiterated Rating ,

Ascendis Pharma A/S (NASDAQ:ASND) Rating Reiterated by 3M

3M reaffirmed their maintains rating on shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Rating) in a research note issued to investors on Friday morning, Benzinga reports. Several other research analysts also recently commented on ASND. Cantor Fitzgerald increased their price objective on Ascendis Pharma A/S from $142.00 to $152.00 in a research note on […] ....

United States , Ascendis Pharma , Jan Moller Mikkelsen , Dirk Vetter , Harald Rau , Blackrock Inc , Envestnet Asset Management Inc , Affinity Asset Advisors , Credit Suisse Group , York Mellon Corp , Morgan Stanley , Ascendis Pharmaas Company Profile , Cantor Fitzgerald , Wells Fargo Company , Rice Hall James Associates , Get Rating , Wells Fargo , Suisse Group , Moderate Buy , Asset Management , Hall James , New York Mellon Corp , Ascendis Pharmaa S , Nasdaq Asnd , Reiterated Rating ,

Berenberg Bank Keeps Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Ascendis Pharma (ASND – Research Report), wi. ....

Caroline Palomeque , Jan Moller Mikkelsen , Harald Rau , Goldman Sachs Paul Choi , Ascendis Pharma , Credit Suisse , Berenberg Bank , Research Report , Goldman Sachs , Paul Choi ,

3M Reiterates Maintains Rating for Ascendis Pharma A/S (NASDAQ:ASND)

Ascendis Pharma A/S (NASDAQ:ASND – Get Rating)‘s stock had its “maintains” rating reissued by 3M in a research report issued to clients and investors on Friday, Benzinga reports. A number of other research analysts have also issued reports on ASND. Cantor Fitzgerald boosted their price target on Ascendis Pharma A/S from $142.00 to $152.00 in […] ....

Harald Rau , Jan Moller Mikkelsen , Ascendis Pharma , Dirk Vetter , Guggenheim Capital , Cantor Fitzgerald , Nelson Van Denburg Campbell Wealth Management Group , Quadrant Capital Group , Envestnet Asset Management Inc , Wells Fargo Company , Credit Suisse Group , Ascendis Pharmaas Company Profile , Get Rating , Suisse Group , Capital Group , Asset Management , Van Denburg , Campbell Wealth Management Group , Ascendis Pharmaa S , Nasdaq Asnd , Reiterated Rating ,